TrialBMC nephrology2014

A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design.

Hidetomo Nakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.